MAXVAX Biotechnology Limited Liability Company
MAXVAX Biotechnology Limited Liability Company
Explore linked clinical trials.10 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Immune Response Features Following Vaccination With a Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells) | Respiratory Syncytial Virus (RSV) | Not yet recruiting | Not applicable | 2026-06-01 | NCT07618325 | |
| Safety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV) Vaccine (MKK900) in Healthy Adult Women | Respiratory Syncytial Virus (RSV) | Not yet recruiting | Phase 1 | 2026-03-25 | NCT07492706 | |
| A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell) | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, herpes zoster, viral infectious disease | Active, not recruiting | Phase 3 | 2026-03-10 | NCT07293065 | |
| Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell) | Respiratory Syncytial Virus (RSV) | Recruiting | Phase 3 | 2025-12-09 | NCT07272434 | |
| Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above | Respiratory Syncytial Virus (RSV) | Active, not recruiting | Phase 1 / Phase 2 | 2025-06-06 | NCT06642558 | |
| Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell). | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, herpes zoster, viral infectious disease | Not yet recruiting | Phase 3 | 2024-11-20 | NCT06654700 | |
| Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, herpes zoster, viral infectious disease | Active, not recruiting | Phase 2 | 2024-11-20 | NCT05856084 | |
| Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, herpes zoster, viral infectious disease | Active, not recruiting | Phase 1 | 2024-11-20 | NCT05636436 | |
| Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers | Digestive System Diseases, Infections, RNA Virus Infections, Reoviridae infectious disease, Rotavirus infection, digestive system disorder, gastroenteritis, viral infectious disease | Active, not recruiting | Phase 2 | 2024-11-20 | NCT05621655 | |
| Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, herpes zoster, viral infectious disease | Active, not recruiting | Phase 3 | 2024-10-24 | NCT06447779 |